| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane transporter activity | SPNS1 CACNG1 TMEM241 SLC39A2 SLC26A4 SLC35C2 SLC2A14 FXYD4 AQP8 ASIC5 SLC1A2 SLC4A3 ABCC6 SLC22A18 SLC9B1 SLC9A4 CACNG7 CACNG6 SLC8B1 SLC9A5 SLC12A9 SLC16A2 SV2B SLC49A3 CACNG5 CACNG4 ATP13A3 SERINC5 SLC52A2 SLC39A5 SLC27A5 | 1.79e-14 | 1180 | 103 | 31 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | SPNS1 CACNG1 TMEM241 SLC39A2 SLC26A4 SLC35C2 SLC2A14 FXYD4 AQP8 ASIC5 SLC1A2 SLC4A3 ABCC6 SLC22A18 SLC9B1 SLC9A4 CACNG7 CACNG6 SLC8B1 SLC9A5 SLC12A9 SLC16A2 SV2B SLC49A3 CACNG5 CACNG4 ATP13A3 SERINC5 SLC52A2 SLC39A5 SLC27A5 | 1.92e-13 | 1289 | 103 | 31 | GO:0005215 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | TMEM241 SLC26A4 SLC35C2 SLC1A2 SLC4A3 SLC22A18 SLC9B1 SLC9A4 SLC8B1 SLC9A5 SLC12A9 SLC16A2 SLC39A5 | 4.17e-09 | 296 | 103 | 13 | GO:0015291 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | CACNG1 SLC39A2 SLC26A4 FXYD4 AQP8 ASIC5 SLC1A2 SLC4A3 ABCC6 SLC9B1 SLC9A4 CACNG7 CACNG6 SLC8B1 SLC9A5 SLC12A9 CACNG5 CACNG4 SLC39A5 | 9.97e-09 | 758 | 103 | 19 | GO:0015318 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CACNG1 SLC39A2 FXYD4 ASIC5 SLC1A2 SLC9B1 SLC9A4 CACNG7 CACNG6 SLC8B1 SLC9A5 SLC12A9 CACNG5 CACNG4 SLC39A5 | 1.61e-08 | 465 | 103 | 15 | GO:0046873 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | TMEM241 SLC26A4 SLC35C2 SLC1A2 SLC4A3 ABCC6 SLC22A18 SLC9B1 SLC9A4 SLC8B1 SLC9A5 SLC12A9 SLC16A2 ATP13A3 SLC39A5 | 2.25e-08 | 477 | 103 | 15 | GO:0022804 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | CACNG1 SLC39A2 SLC26A4 FXYD4 ASIC5 SLC1A2 SLC4A3 SLC9B1 SLC9A4 CACNG7 CACNG6 SLC8B1 SLC9A5 SLC12A9 CACNG5 CACNG4 ATP13A3 SLC39A5 | 1.15e-07 | 793 | 103 | 18 | GO:0015075 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | CACNG1 SLC39A2 FXYD4 AQP8 ASIC5 SLC1A2 SLC9B1 SLC9A4 CACNG7 CACNG6 SLC8B1 SLC9A5 SLC12A9 CACNG5 CACNG4 SLC39A5 | 1.32e-07 | 627 | 103 | 16 | GO:0022890 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CACNG1 SLC39A2 FXYD4 ASIC5 SLC1A2 SLC9B1 SLC9A4 CACNG7 CACNG6 SLC8B1 SLC9A5 SLC12A9 CACNG5 CACNG4 ATP13A3 SLC39A5 | 2.85e-07 | 664 | 103 | 16 | GO:0008324 |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | TMEM241 SLC26A4 SLC2A14 SLC1A2 SLC4A3 SLC22A18 SLC16A2 SERINC5 SLC52A2 SLC39A5 SLC27A5 | 3.39e-07 | 293 | 103 | 11 | GO:0008514 |
| GeneOntologyMolecularFunction | antiporter activity | 5.81e-07 | 138 | 103 | 8 | GO:0015297 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | SLC26A4 SLC1A2 SLC4A3 SLC9B1 SLC9A4 SLC8B1 SLC9A5 SLC12A9 ATP13A3 SLC39A5 | 3.58e-06 | 301 | 103 | 10 | GO:0022853 |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 3.84e-06 | 46 | 103 | 5 | GO:0005245 | |
| GeneOntologyMolecularFunction | calcium channel regulator activity | 8.57e-06 | 54 | 103 | 5 | GO:0005246 | |
| GeneOntologyMolecularFunction | MHC class II protein complex binding | 1.07e-05 | 27 | 103 | 4 | GO:0023026 | |
| GeneOntologyMolecularFunction | channel regulator activity | 3.32e-05 | 174 | 103 | 7 | GO:0016247 | |
| GeneOntologyMolecularFunction | transporter regulator activity | 3.70e-05 | 177 | 103 | 7 | GO:0141108 | |
| GeneOntologyMolecularFunction | complement receptor activity | 4.66e-05 | 14 | 103 | 3 | GO:0004875 | |
| GeneOntologyMolecularFunction | MHC protein complex binding | 5.84e-05 | 41 | 103 | 4 | GO:0023023 | |
| GeneOntologyMolecularFunction | metal cation:monoatomic cation antiporter activity | 7.06e-05 | 43 | 103 | 4 | GO:0140828 | |
| GeneOntologyMolecularFunction | sodium:proton antiporter activity | 7.11e-05 | 16 | 103 | 3 | GO:0015385 | |
| GeneOntologyMolecularFunction | peptide antigen binding | 1.18e-04 | 49 | 103 | 4 | GO:0042605 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.32e-04 | 151 | 103 | 6 | GO:0015085 | |
| GeneOntologyMolecularFunction | ion channel regulator activity | 1.94e-04 | 162 | 103 | 6 | GO:0099106 | |
| GeneOntologyMolecularFunction | immune receptor activity | 2.15e-04 | 165 | 103 | 6 | GO:0140375 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 2.60e-04 | 171 | 103 | 6 | GO:0015081 | |
| GeneOntologyMolecularFunction | N-formyl peptide receptor activity | 2.61e-04 | 5 | 103 | 2 | GO:0004982 | |
| GeneOntologyMolecularFunction | metal cation:proton antiporter activity | 3.56e-04 | 27 | 103 | 3 | GO:0051139 | |
| GeneOntologyMolecularFunction | calcium channel activity | 5.49e-04 | 129 | 103 | 5 | GO:0005262 | |
| GeneOntologyMolecularFunction | bicarbonate transmembrane transporter activity | 5.93e-04 | 32 | 103 | 3 | GO:0015106 | |
| GeneOntologyMolecularFunction | organic cation transmembrane transporter activity | 8.98e-04 | 83 | 103 | 4 | GO:0015101 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 1.15e-03 | 152 | 103 | 5 | GO:0022843 | |
| GeneOntologyMolecularFunction | ubiquitin-like modifier activating enzyme activity | 1.15e-03 | 10 | 103 | 2 | GO:0008641 | |
| GeneOntologyMolecularFunction | ligase activity, forming carbon-sulfur bonds | 1.23e-03 | 41 | 103 | 3 | GO:0016877 | |
| GeneOntologyMolecularFunction | MHC class II receptor activity | 1.41e-03 | 11 | 103 | 2 | GO:0032395 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR2A14 GPR31 GPR32 GPR32P1 HLA-DOA HLA-DPA1 LGR4 PTPRU GPR162 OR52N1 OR2W3 NRXN3 CSF2RA CMKLR1 ADGRF3 OR2A2 | 1.50e-03 | 1353 | 103 | 16 | GO:0004888 |
| GeneOntologyMolecularFunction | chloride:bicarbonate antiporter activity | 1.98e-03 | 13 | 103 | 2 | GO:0140900 | |
| GeneOntologyMolecularFunction | bicarbonate:monoatomic anion antiporter activity | 1.98e-03 | 13 | 103 | 2 | GO:0140829 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 2.01e-03 | 343 | 103 | 7 | GO:0005261 | |
| GeneOntologyMolecularFunction | potassium:proton antiporter activity | 2.30e-03 | 14 | 103 | 2 | GO:0015386 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 2.54e-03 | 182 | 103 | 5 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 2.66e-03 | 184 | 103 | 5 | GO:0022832 | |
| GeneOntologyMolecularFunction | antigen binding | 3.05e-03 | 190 | 103 | 5 | GO:0003823 | |
| GeneOntologyMolecularFunction | long-chain fatty acyl-CoA hydrolase activity | 3.41e-03 | 17 | 103 | 2 | GO:0052816 | |
| GeneOntologyMolecularFunction | sulfur compound transmembrane transporter activity | 3.86e-03 | 61 | 103 | 3 | GO:1901682 | |
| GeneOntologyMolecularFunction | solute:potassium antiporter activity | 4.26e-03 | 19 | 103 | 2 | GO:0022821 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 4.39e-03 | 207 | 103 | 5 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 4.48e-03 | 208 | 103 | 5 | GO:0005342 | |
| GeneOntologyMolecularFunction | protein-hormone receptor activity | 5.69e-03 | 22 | 103 | 2 | GO:0016500 | |
| GeneOntologyMolecularFunction | channel activity | 5.81e-03 | 525 | 103 | 8 | GO:0015267 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR2A14 GPR31 GPR32 GPR32P1 LGR4 GPR162 OR52N1 OR2W3 CMKLR1 ADGRF3 OR2A2 | 5.88e-03 | 884 | 103 | 11 | GO:0004930 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 5.88e-03 | 526 | 103 | 8 | GO:0022803 | |
| GeneOntologyMolecularFunction | zinc ion transmembrane transporter activity | 6.75e-03 | 24 | 103 | 2 | GO:0005385 | |
| GeneOntologyMolecularFunction | symporter activity | 7.61e-03 | 150 | 103 | 4 | GO:0015293 | |
| GeneOntologyMolecularFunction | gated channel activity | 7.71e-03 | 334 | 103 | 6 | GO:0022836 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 7.79e-03 | 151 | 103 | 4 | GO:0008509 | |
| GeneOntologyMolecularFunction | fatty acyl-CoA hydrolase activity | 8.50e-03 | 27 | 103 | 2 | GO:0047617 | |
| GeneOntologyMolecularFunction | acyl-CoA hydrolase activity | 9.13e-03 | 28 | 103 | 2 | GO:0016289 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 9.69e-03 | 459 | 103 | 7 | GO:0005216 | |
| GeneOntologyBiologicalProcess | organic anion transport | TMEM241 SLC26A4 SLC35C2 SLC2A14 AQP8 SLC1A2 SLC4A3 ABCC6 SLC16A2 PLA2G6 SERINC5 SLC52A2 SLC39A5 SLC27A5 | 3.52e-07 | 515 | 105 | 14 | GO:0015711 |
| GeneOntologyBiologicalProcess | MHC class II protein complex assembly | 1.10e-06 | 16 | 105 | 4 | GO:0002399 | |
| GeneOntologyBiologicalProcess | peptide antigen assembly with MHC class II protein complex | 1.10e-06 | 16 | 105 | 4 | GO:0002503 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | CACNG1 SLC39A2 SLC26A4 FXYD4 CLDN15 ASIC5 SLC1A2 SLC4A3 ABCC6 SLC22A18 SLC9B1 SLC9A4 CACNG7 CACNG6 SLC8B1 SLC9A5 SLC12A9 CACNG5 CACNG4 ATP13A3 LTF SLC39A5 | 1.29e-06 | 1374 | 105 | 22 | GO:0006811 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | CACNG1 SLC39A2 SLC26A4 FXYD4 ASIC5 SLC1A2 SLC4A3 ABCC6 SLC9B1 SLC9A4 CACNG7 CACNG6 SLC8B1 SLC9A5 SLC12A9 CACNG5 CACNG4 ATP13A3 SLC39A5 | 3.15e-06 | 1115 | 105 | 19 | GO:0034220 |
| GeneOntologyBiologicalProcess | MHC protein complex assembly | 3.55e-06 | 21 | 105 | 4 | GO:0002396 | |
| GeneOntologyBiologicalProcess | peptide antigen assembly with MHC protein complex | 3.55e-06 | 21 | 105 | 4 | GO:0002501 | |
| GeneOntologyBiologicalProcess | neurotransmitter receptor transport, postsynaptic endosome to lysosome | 7.05e-06 | 8 | 105 | 3 | GO:0098943 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | CACNG1 SLC39A2 SLC26A4 FXYD4 AQP8 ASIC5 SLC4A3 SLC9B1 SLC9A4 CACNG7 CACNG6 SLC8B1 SLC9A5 SLC12A9 CACNG5 CACNG4 SLC39A5 | 1.43e-05 | 1017 | 105 | 17 | GO:0098660 |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen via MHC class II | 2.04e-05 | 32 | 105 | 4 | GO:0019886 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class II | 3.29e-05 | 36 | 105 | 4 | GO:0002495 | |
| GeneOntologyBiologicalProcess | regulation of pH | 3.44e-05 | 120 | 105 | 6 | GO:0006885 | |
| GeneOntologyBiologicalProcess | neurotransmitter receptor diffusion trapping | 3.53e-05 | 13 | 105 | 3 | GO:0099628 | |
| GeneOntologyBiologicalProcess | postsynaptic neurotransmitter receptor diffusion trapping | 3.53e-05 | 13 | 105 | 3 | GO:0098970 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 4.10e-05 | 38 | 105 | 4 | GO:0002504 | |
| GeneOntologyBiologicalProcess | receptor diffusion trapping | 4.48e-05 | 14 | 105 | 3 | GO:0098953 | |
| GeneOntologyBiologicalProcess | monoatomic cation homeostasis | SPNS1 SLC26A4 SLC4A3 ABCC6 RMDN3 SLC9B1 SLC9A4 SLC8B1 SLC9A5 SLC12A9 SV2B ATP13A3 SLC39A5 | 6.03e-05 | 705 | 105 | 13 | GO:0055080 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | CACNG1 SLC39A2 FXYD4 AQP8 ASIC5 SLC9B1 SLC9A4 CACNG7 CACNG6 SLC8B1 SLC9A5 SLC12A9 CACNG5 CACNG4 SLC39A5 | 6.57e-05 | 922 | 105 | 15 | GO:0098662 |
| GeneOntologyBiologicalProcess | complement receptor mediated signaling pathway | 6.84e-05 | 16 | 105 | 3 | GO:0002430 | |
| GeneOntologyBiologicalProcess | monoatomic ion homeostasis | SPNS1 SLC26A4 SLC4A3 ABCC6 RMDN3 SLC9B1 SLC9A4 SLC8B1 SLC9A5 SLC12A9 SV2B ATP13A3 SLC39A5 | 7.15e-05 | 717 | 105 | 13 | GO:0050801 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | CACNG1 SLC39A2 FXYD4 ASIC5 SLC9B1 SLC9A4 CACNG7 CACNG6 SLC8B1 SLC9A5 SLC12A9 CACNG5 CACNG4 ATP13A3 SLC39A5 | 8.35e-05 | 942 | 105 | 15 | GO:0098655 |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen | 1.04e-04 | 48 | 105 | 4 | GO:0002478 | |
| GeneOntologyBiologicalProcess | regulation of intracellular pH | 1.19e-04 | 94 | 105 | 5 | GO:0051453 | |
| GeneOntologyBiologicalProcess | carbohydrate derivative transport | 1.31e-04 | 96 | 105 | 5 | GO:1901264 | |
| GeneOntologyBiologicalProcess | metal ion transport | CACNG1 SLC39A2 FXYD4 ASIC5 SLC9B1 SLC9A4 CACNG7 CACNG6 SLC8B1 SLC9A5 SLC12A9 CACNG5 CACNG4 LTF SLC39A5 | 1.61e-04 | 1000 | 105 | 15 | GO:0030001 |
| GeneOntologyBiologicalProcess | regulation of cellular pH | 1.67e-04 | 101 | 105 | 5 | GO:0030641 | |
| GeneOntologyBiologicalProcess | import across plasma membrane | 1.76e-04 | 230 | 105 | 7 | GO:0098739 | |
| GeneOntologyBiologicalProcess | chemical homeostasis | SPNS1 PDE3B SLC26A4 SLC4A3 ABCC6 RMDN3 SLC9B1 SLC9A4 SLC8B1 SLC9A5 SLC12A9 SV2B SCARB1 DISP3 PLA2G6 ATP13A3 SLC39A5 | 1.83e-04 | 1249 | 105 | 17 | GO:0048878 |
| GeneOntologyBiologicalProcess | neurotransmitter receptor internalization | 2.18e-04 | 58 | 105 | 4 | GO:0099590 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous antigen | 2.18e-04 | 58 | 105 | 4 | GO:0019884 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | CACNG1 SLC39A2 FXYD4 ASIC5 SLC9B1 SLC9A4 CACNG7 CACNG6 SLC8B1 SLC9A5 SLC12A9 CACNG5 CACNG4 ATP13A3 LTF SLC39A5 | 2.42e-04 | 1157 | 105 | 16 | GO:0006812 |
| GeneOntologyBiologicalProcess | regulation of AMPA receptor activity | 2.72e-04 | 25 | 105 | 3 | GO:2000311 | |
| GeneOntologyBiologicalProcess | monoatomic anion transport | 3.50e-04 | 183 | 105 | 6 | GO:0006820 | |
| GeneOntologyBiologicalProcess | cellular homeostasis | SPNS1 PDE3B SLC4A3 ABCC6 RMDN3 SLC9B1 SLC9A4 SLC8B1 SLC9A5 SLC12A9 SV2B PLA2G6 ATP13A3 SLC39A5 | 4.49e-04 | 981 | 105 | 14 | GO:0019725 |
| GeneOntologyBiologicalProcess | intracellular chemical homeostasis | SPNS1 PDE3B SLC4A3 ABCC6 RMDN3 SLC9B1 SLC9A4 SLC8B1 SLC9A5 SV2B PLA2G6 ATP13A3 SLC39A5 | 4.53e-04 | 866 | 105 | 13 | GO:0055082 |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen | 6.14e-04 | 76 | 105 | 4 | GO:0048002 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 6.88e-04 | 208 | 105 | 6 | GO:0035725 | |
| GeneOntologyBiologicalProcess | bicellular tight junction assembly | 7.81e-04 | 81 | 105 | 4 | GO:0070830 | |
| GeneOntologyBiologicalProcess | organic cation transport | 8.80e-04 | 145 | 105 | 5 | GO:0015695 | |
| GeneOntologyBiologicalProcess | bicarbonate transport | 9.50e-04 | 38 | 105 | 3 | GO:0015701 | |
| GeneOntologyBiologicalProcess | transepithelial transport | 9.50e-04 | 38 | 105 | 3 | GO:0070633 | |
| GeneOntologyBiologicalProcess | tight junction assembly | 1.07e-03 | 88 | 105 | 4 | GO:0120192 | |
| GeneOntologyBiologicalProcess | import into cell | AQP8 SLC1A2 VAC14 SLC9A4 CACNG7 SLC9A5 SLC16A2 SCARB1 PLA2G6 CACNG5 CACNG4 CLEC10A SLC39A5 SLC27A5 | 1.09e-03 | 1074 | 105 | 14 | GO:0098657 |
| GeneOntologyBiologicalProcess | intracellular monoatomic cation homeostasis | SPNS1 SLC4A3 RMDN3 SLC9B1 SLC9A4 SLC8B1 SLC9A5 SV2B ATP13A3 SLC39A5 | 1.12e-03 | 611 | 105 | 10 | GO:0030003 |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | 1.12e-03 | 153 | 105 | 5 | GO:0098656 | |
| GeneOntologyBiologicalProcess | positive regulation of chondrocyte proliferation | 1.12e-03 | 10 | 105 | 2 | GO:1902732 | |
| GeneOntologyBiologicalProcess | apical junction assembly | 1.16e-03 | 90 | 105 | 4 | GO:0043297 | |
| GeneOntologyBiologicalProcess | carboxylic acid transport | 1.18e-03 | 410 | 105 | 8 | GO:0046942 | |
| GeneOntologyBiologicalProcess | organic acid transport | 1.22e-03 | 412 | 105 | 8 | GO:0015849 | |
| GeneOntologyBiologicalProcess | positive regulation of immune response | HLA-DMA GPR31 GPR32 GPR32P1 HLA-DOA HLA-DPA1 HLA-DPB1 LGR4 HAVCR2 PLA2G6 CMKLR1 LTF | 1.22e-03 | 845 | 105 | 12 | GO:0050778 |
| GeneOntologyBiologicalProcess | regulation of synaptic transmission, glutamatergic | 1.26e-03 | 92 | 105 | 4 | GO:0051966 | |
| GeneOntologyBiologicalProcess | neurotransmitter receptor transport | 1.27e-03 | 42 | 105 | 3 | GO:0099637 | |
| GeneOntologyBiologicalProcess | intracellular monoatomic ion homeostasis | SPNS1 SLC4A3 RMDN3 SLC9B1 SLC9A4 SLC8B1 SLC9A5 SV2B ATP13A3 SLC39A5 | 1.28e-03 | 622 | 105 | 10 | GO:0006873 |
| GeneOntologyBiologicalProcess | tight junction organization | 1.36e-03 | 94 | 105 | 4 | GO:0120193 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic transmission, glutamatergic | 1.36e-03 | 43 | 105 | 3 | GO:0051968 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane neurotransmitter receptor levels | 1.52e-03 | 164 | 105 | 5 | GO:0099072 | |
| GeneOntologyCellularComponent | L-type voltage-gated calcium channel complex | 3.00e-07 | 12 | 106 | 4 | GO:1990454 | |
| GeneOntologyCellularComponent | MHC class II protein complex | 1.41e-06 | 17 | 106 | 4 | GO:0042613 | |
| GeneOntologyCellularComponent | MHC protein complex | 8.57e-06 | 26 | 106 | 4 | GO:0042611 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 8.65e-05 | 46 | 106 | 4 | GO:0005891 | |
| GeneOntologyCellularComponent | late endosome membrane | 3.05e-04 | 179 | 106 | 6 | GO:0031902 | |
| GeneOntologyCellularComponent | AMPA glutamate receptor complex | 4.66e-04 | 30 | 106 | 3 | GO:0032281 | |
| GeneOntologyCellularComponent | calcium channel complex | 5.20e-04 | 73 | 106 | 4 | GO:0034704 | |
| GeneOntologyCellularComponent | T-tubule | 7.01e-04 | 79 | 106 | 4 | GO:0030315 | |
| GeneOntologyCellularComponent | lumenal side of endoplasmic reticulum membrane | 7.37e-04 | 35 | 106 | 3 | GO:0098553 | |
| GeneOntologyCellularComponent | ionotropic glutamate receptor complex | 1.54e-03 | 45 | 106 | 3 | GO:0008328 | |
| GeneOntologyCellularComponent | lumenal side of membrane | 1.86e-03 | 48 | 106 | 3 | GO:0098576 | |
| GeneOntologyCellularComponent | late endosome | 1.99e-03 | 348 | 106 | 7 | GO:0005770 | |
| GeneOntologyCellularComponent | neurotransmitter receptor complex | 2.09e-03 | 50 | 106 | 3 | GO:0098878 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | CACNG1 HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 FXYD4 CACNG7 CACNG6 CSF2RA CACNG5 CACNG4 | 2.12e-03 | 785 | 106 | 11 | GO:0098797 |
| GeneOntologyCellularComponent | endosome | HLA-DMA PRSS16 HLA-DOA HLA-DPA1 HLA-DPB1 TMBIM1 HAVCR2 VAC14 CACNG7 SLC9A5 KIDINS220 TRAPPC6B ATP13A3 LTF | 2.29e-03 | 1167 | 106 | 14 | GO:0005768 |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 SLC2A14 TMBIM1 VAC14 SLC9A4 SLC9A5 SV2B SCARB1 DISP3 LHFPL2 CACNG4 ATP13A3 | 2.44e-03 | 1307 | 106 | 15 | GO:0030659 |
| GeneOntologyCellularComponent | vesicle membrane | HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 SLC2A14 TMBIM1 VAC14 SLC9A4 SLC9A5 SV2B SCARB1 DISP3 LHFPL2 CACNG4 ATP13A3 | 2.78e-03 | 1325 | 106 | 15 | GO:0012506 |
| GeneOntologyCellularComponent | sarcolemma | 2.84e-03 | 190 | 106 | 5 | GO:0042383 | |
| GeneOntologyCellularComponent | apical plasma membrane | 3.37e-03 | 487 | 106 | 8 | GO:0016324 | |
| GeneOntologyCellularComponent | cell surface | HLA-DMA HLA-DPA1 HLA-DPB1 MUC16 SLC1A2 SLC4A3 HAVCR2 IL1RAPL1 CSF2RA SCARB1 CACNG4 LTF CLEC10A | 4.07e-03 | 1111 | 106 | 13 | GO:0009986 |
| GeneOntologyCellularComponent | vacuolar membrane | 4.29e-03 | 507 | 106 | 8 | GO:0005774 | |
| GeneOntologyCellularComponent | bicellular tight junction | 4.47e-03 | 131 | 106 | 4 | GO:0005923 | |
| Domain | PMP22/EMP/MP20/Claudin | CACNG1 CLDN25 CLDN15 CLDN22 CACNG7 CACNG6 CLDN24 CACNG5 CACNG4 | 1.89e-12 | 45 | 100 | 9 | IPR004031 |
| Domain | PMP22_Claudin | 3.39e-11 | 40 | 100 | 8 | PF00822 | |
| Domain | VDCC_gsu | 2.20e-10 | 8 | 100 | 5 | IPR008368 | |
| Domain | Claudin | 3.55e-07 | 28 | 100 | 5 | IPR006187 | |
| Domain | MFS | 1.83e-06 | 108 | 100 | 7 | PS50850 | |
| Domain | MHC_II_alpha | 2.94e-06 | 6 | 100 | 3 | PF00993 | |
| Domain | MHC_II_a_N | 5.13e-06 | 7 | 100 | 3 | IPR001003 | |
| Domain | MFS_dom | 7.69e-06 | 134 | 100 | 7 | IPR020846 | |
| Domain | Claudin_2 | 1.22e-05 | 9 | 100 | 3 | PF13903 | |
| Domain | Ig/MHC_CS | 1.46e-05 | 58 | 100 | 5 | IPR003006 | |
| Domain | IG_MHC | 1.72e-05 | 60 | 100 | 5 | PS00290 | |
| Domain | Na_H_Exchanger | 5.19e-05 | 14 | 100 | 3 | PF00999 | |
| Domain | MHC_II_a/b_N | 5.19e-05 | 14 | 100 | 3 | IPR014745 | |
| Domain | Cation/H_exchanger | 5.19e-05 | 14 | 100 | 3 | IPR006153 | |
| Domain | - | 5.19e-05 | 14 | 100 | 3 | 3.10.320.10 | |
| Domain | MFS_1 | 5.79e-05 | 77 | 100 | 5 | PF07690 | |
| Domain | MFS | 5.79e-05 | 77 | 100 | 5 | IPR011701 | |
| Domain | IG_LIKE | HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 PTPRU HAVCR2 IL1RAPL1 CD7 SIGLEC10 CNTN3 LRIT1 | 6.38e-05 | 491 | 100 | 11 | PS50835 |
| Domain | Ig-like_dom | HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 PTPRU HAVCR2 IL1RAPL1 CD7 SIGLEC10 CNTN3 LRIT1 | 7.91e-05 | 503 | 100 | 11 | IPR007110 |
| Domain | Ig-like_fold | HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 PTPRU HAVCR2 IL1RAPL1 CD7 CSF2RA SIGLEC10 CNTN3 ADGRF3 LRIT1 | 9.92e-05 | 706 | 100 | 13 | IPR013783 |
| Domain | UBQ-activ_enz_E1_Cys_AS | 1.69e-04 | 4 | 100 | 2 | IPR033127 | |
| Domain | UBQ-activ_enz_E1_CS | 1.69e-04 | 4 | 100 | 2 | IPR018074 | |
| Domain | Claudin_CS | 2.13e-04 | 22 | 100 | 3 | IPR017974 | |
| Domain | CLAUDIN | 2.13e-04 | 22 | 100 | 3 | PS01346 | |
| Domain | IGc1 | 2.30e-04 | 56 | 100 | 4 | SM00407 | |
| Domain | Ig_C1-set | 2.63e-04 | 58 | 100 | 4 | IPR003597 | |
| Domain | C1-set_C | 2.81e-04 | 5 | 100 | 2 | PF16196 | |
| Domain | UBIQUITIN_ACTIVAT_1 | 2.81e-04 | 5 | 100 | 2 | PS00536 | |
| Domain | C1-set_C | 2.81e-04 | 5 | 100 | 2 | IPR032431 | |
| Domain | UBIQUITIN_ACTIVAT_2 | 2.81e-04 | 5 | 100 | 2 | PS00865 | |
| Domain | UBA_E1_Cys | 2.81e-04 | 5 | 100 | 2 | IPR019572 | |
| Domain | MHC_II_alpha | 2.81e-04 | 5 | 100 | 2 | SM00920 | |
| Domain | UBA_e1_thiolCys | 2.81e-04 | 5 | 100 | 2 | PF10585 | |
| Domain | UBQ/SUMO-activ_enz_E1-like | 4.20e-04 | 6 | 100 | 2 | IPR000011 | |
| Domain | - | HLA-DOA HLA-DPA1 HLA-DPB1 PTPRU HAVCR2 IL1RAPL1 CD7 CSF2RA SIGLEC10 CNTN3 LRIT1 | 8.37e-04 | 663 | 100 | 11 | 2.60.40.10 |
| Domain | NaH_exchanger | 9.97e-04 | 9 | 100 | 2 | IPR004709 | |
| Domain | MHC_I/II-like_Ag-recog | 1.10e-03 | 38 | 100 | 3 | IPR011162 | |
| Domain | ThiF_NAD_FAD-bd | 1.24e-03 | 10 | 100 | 2 | IPR000594 | |
| Domain | ThiF | 1.24e-03 | 10 | 100 | 2 | PF00899 | |
| Domain | Cation/H_exchanger_CPA1 | 1.51e-03 | 11 | 100 | 2 | IPR018422 | |
| Domain | Zip | 2.48e-03 | 14 | 100 | 2 | PF02535 | |
| Domain | ZIP | 2.48e-03 | 14 | 100 | 2 | IPR003689 | |
| Domain | C1-set | 3.03e-03 | 54 | 100 | 3 | PF07654 | |
| Domain | ig | 3.57e-03 | 190 | 100 | 5 | PF00047 | |
| Domain | Immunoglobulin | 3.57e-03 | 190 | 100 | 5 | IPR013151 | |
| Domain | Leu-rich_rpt_Cys-con_subtyp | 4.57e-03 | 19 | 100 | 2 | IPR006553 | |
| Domain | LRR_CC | 4.57e-03 | 19 | 100 | 2 | SM00367 | |
| Domain | LRR_1 | 6.48e-03 | 219 | 100 | 5 | PF00560 | |
| Domain | IG | 7.48e-03 | 421 | 100 | 7 | SM00409 | |
| Domain | Ig_sub | 7.48e-03 | 421 | 100 | 7 | IPR003599 | |
| Domain | GPCR_Rhodpsn_7TM | 9.76e-03 | 670 | 100 | 9 | IPR017452 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CARDIAC_TYPE_VGCC_RYR_SIGNALING | 1.18e-07 | 21 | 83 | 5 | M47950 | |
| Pathway | KEGG_MEDICUS_REFERENCE_SKELETAL_TYPE_VGCC_RYR_SIGNALING | 1.18e-07 | 21 | 83 | 5 | M47949 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | LMF1 SLC39A2 SLC26A4 SLC2A14 FXYD4 AQP8 ASIC5 SLC1A2 SLC4A3 ABCC6 SLC22A18 SLC9B1 SLC9A4 SLC8B1 SLC9A5 SLC16A2 SCARB1 SLC39A5 | 2.06e-07 | 736 | 83 | 18 | M27287 |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC39A2 SLC26A4 SLC2A14 SLC1A2 SLC4A3 SLC22A18 SLC9A4 SLC8B1 SLC9A5 SLC16A2 SLC39A5 | 2.20e-07 | 249 | 83 | 11 | M5988 |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 3.03e-07 | 25 | 83 | 5 | M47948 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | LMF1 SLC39A2 SLC26A4 SLC2A14 FXYD4 AQP8 ASIC5 SLC1A2 SLC4A3 ABCC6 SLC22A18 SLC9B1 SLC9A4 SLC8B1 SLC9A5 SLC16A2 SCARB1 | 3.57e-07 | 681 | 83 | 17 | MM14985 |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC39A2 SLC26A4 SLC2A14 SLC1A2 SLC4A3 SLC22A18 SLC9A4 SLC8B1 SLC9A5 SLC16A2 | 1.29e-06 | 238 | 83 | 10 | MM15076 |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_NFY_MEDIATED_TRANSCRIPTION | 1.45e-06 | 15 | 83 | 4 | M47588 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_II_MOLECULES | 1.45e-06 | 15 | 83 | 4 | M47604 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 1.08e-05 | 8 | 83 | 3 | MM15197 | |
| Pathway | KEGG_CELL_ADHESION_MOLECULES_CAMS | 1.30e-05 | 133 | 83 | 7 | M16476 | |
| Pathway | KEGG_ASTHMA | 2.72e-05 | 30 | 83 | 4 | M13950 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 4.11e-05 | 108 | 83 | 6 | M823 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 4.33e-05 | 109 | 83 | 6 | MM15074 | |
| Pathway | KEGG_ALLOGRAFT_REJECTION | 6.36e-05 | 37 | 83 | 4 | M18615 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TIGHT_JUNCTION_ACTIN_SIGNALING_PATHWAY | 6.36e-05 | 37 | 83 | 4 | M47769 | |
| Pathway | REACTOME_PHASE_2_PLATEAU_PHASE | 6.84e-05 | 14 | 83 | 3 | MM15198 | |
| Pathway | WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY | 7.34e-05 | 74 | 83 | 5 | M39462 | |
| Pathway | KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC | 7.34e-05 | 74 | 83 | 5 | M16376 | |
| Pathway | REACTOME_PHASE_2_PLATEAU_PHASE | 8.51e-05 | 15 | 83 | 3 | M27456 | |
| Pathway | KEGG_GRAFT_VERSUS_HOST_DISEASE | 9.58e-05 | 41 | 83 | 4 | M13519 | |
| Pathway | KEGG_CARDIAC_MUSCLE_CONTRACTION | 1.00e-04 | 79 | 83 | 5 | M17673 | |
| Pathway | WP_EBOLA_VIRUS_INFECTION_IN_HOST | 1.11e-04 | 129 | 83 | 6 | M39693 | |
| Pathway | KEGG_TYPE_I_DIABETES_MELLITUS | 1.16e-04 | 43 | 83 | 4 | M12617 | |
| Pathway | KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM | 1.27e-04 | 83 | 83 | 5 | M8728 | |
| Pathway | KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION | 1.78e-04 | 48 | 83 | 4 | M615 | |
| Pathway | KEGG_DILATED_CARDIOMYOPATHY | 1.86e-04 | 90 | 83 | 5 | M835 | |
| Pathway | KEGG_AUTOIMMUNE_THYROID_DISEASE | 2.44e-04 | 52 | 83 | 4 | M13103 | |
| Pathway | KEGG_VIRAL_MYOCARDITIS | 7.62e-04 | 70 | 83 | 4 | M12294 | |
| Pathway | KEGG_LEISHMANIA_INFECTION | 8.48e-04 | 72 | 83 | 4 | M3126 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 8.63e-04 | 32 | 83 | 3 | M27455 | |
| Pathway | REACTOME_SODIUM_PROTON_EXCHANGERS | 1.20e-03 | 9 | 83 | 2 | M27337 | |
| Pathway | REACTOME_SODIUM_PROTON_EXCHANGERS | 1.20e-03 | 9 | 83 | 2 | MM15079 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | 1.41e-03 | 367 | 83 | 8 | M48346 | |
| Pathway | REACTOME_ZINC_INFLUX_INTO_CELLS_BY_THE_SLC39_GENE_FAMILY | 1.49e-03 | 10 | 83 | 2 | M27361 | |
| Pathway | KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION | 1.79e-03 | 88 | 83 | 4 | M16004 | |
| Pathway | WP_ALLOGRAFT_REJECTION | 1.87e-03 | 89 | 83 | 4 | M39398 | |
| Pathway | WP_GPCRS_ODORANT | 2.32e-03 | 157 | 83 | 5 | MM15872 | |
| Pathway | REACTOME_LGI_ADAM_INTERACTIONS | 2.98e-03 | 14 | 83 | 2 | MM15277 | |
| Pathway | REACTOME_LGI_ADAM_INTERACTIONS | 2.98e-03 | 14 | 83 | 2 | M27564 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 3.17e-03 | 103 | 83 | 4 | MM15196 | |
| Pathway | WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS | 3.42e-03 | 15 | 83 | 2 | M39789 | |
| Pathway | REACTOME_ZINC_TRANSPORTERS | 3.42e-03 | 15 | 83 | 2 | M832 | |
| Pathway | WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS | 3.90e-03 | 16 | 83 | 2 | MM15813 | |
| Pubmed | Calcium channel gamma subunits provide insights into the evolution of this gene family. | 5.00e-12 | 7 | 106 | 5 | 11738816 | |
| Pubmed | Calcium channel gamma subunits: a functionally diverse protein family. | 1.33e-11 | 8 | 106 | 5 | 17652770 | |
| Pubmed | 2.98e-11 | 9 | 106 | 5 | 11170751 | ||
| Pubmed | HIV-1 Nef impairs MHC class II antigen presentation and surface expression. | 3.96e-08 | 12 | 106 | 4 | 11593029 | |
| Pubmed | 3.96e-08 | 12 | 106 | 4 | 12970439 | ||
| Pubmed | HLA class II antigens and the HIV envelope glycoprotein gp120 bind to the same face of CD4. | 7.97e-08 | 14 | 106 | 4 | 7512597 | |
| Pubmed | Interaction of CD4 with HLA class II antigens and HIV gp120. | 7.97e-08 | 14 | 106 | 4 | 1869305 | |
| Pubmed | 1.08e-07 | 15 | 106 | 4 | 8376762 | ||
| Pubmed | 1.08e-07 | 15 | 106 | 4 | 8168144 | ||
| Pubmed | Strategy for identifying dendritic cell-processed CD4+ T cell epitopes from the HIV gag p24 protein. | 1.08e-07 | 15 | 106 | 4 | 22860026 | |
| Pubmed | 1.08e-07 | 15 | 106 | 4 | 7602119 | ||
| Pubmed | 1.08e-07 | 15 | 106 | 4 | 1967269 | ||
| Pubmed | 1.08e-07 | 15 | 106 | 4 | 9079699 | ||
| Pubmed | 1.08e-07 | 15 | 106 | 4 | 3489470 | ||
| Pubmed | 1.08e-07 | 15 | 106 | 4 | 10729169 | ||
| Pubmed | Cardiac L-type calcium channel (Cav1.2) associates with gamma subunits. | 1.10e-07 | 4 | 106 | 3 | 21127204 | |
| Pubmed | Tight junction-based epithelial microenvironment and cell proliferation. | 1.10e-07 | 4 | 106 | 3 | 19029935 | |
| Pubmed | 1.10e-07 | 4 | 106 | 3 | 10613843 | ||
| Pubmed | 1.10e-07 | 4 | 106 | 3 | 27102562 | ||
| Pubmed | Inhibition of CD4+ T cell function by the HIV envelope protein, gp120. | 1.44e-07 | 16 | 106 | 4 | 2846691 | |
| Pubmed | 1.44e-07 | 16 | 106 | 4 | 1978941 | ||
| Pubmed | Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding. | 1.44e-07 | 16 | 106 | 4 | 2543930 | |
| Pubmed | 1.44e-07 | 16 | 106 | 4 | 17959659 | ||
| Pubmed | 1.88e-07 | 17 | 106 | 4 | 15194762 | ||
| Pubmed | 1.88e-07 | 17 | 106 | 4 | 24904546 | ||
| Pubmed | HIV-1 Nef promotes endocytosis of cell surface MHC class II molecules via a constitutive pathway. | 2.41e-07 | 18 | 106 | 4 | 19620308 | |
| Pubmed | 2.41e-07 | 18 | 106 | 4 | 11118314 | ||
| Pubmed | 2.41e-07 | 18 | 106 | 4 | 10661406 | ||
| Pubmed | Nef performance in macrophages: the master orchestrator of viral persistence and spread. | 3.80e-07 | 20 | 106 | 4 | 22103834 | |
| Pubmed | 3.80e-07 | 20 | 106 | 4 | 7541827 | ||
| Pubmed | 3.80e-07 | 20 | 106 | 4 | 12427289 | ||
| Pubmed | 4.69e-07 | 21 | 106 | 4 | 21778700 | ||
| Pubmed | 4.69e-07 | 21 | 106 | 4 | 8084338 | ||
| Pubmed | 6.90e-07 | 23 | 106 | 4 | 18036336 | ||
| Pubmed | 6.90e-07 | 23 | 106 | 4 | 19770068 | ||
| Pubmed | 6.90e-07 | 23 | 106 | 4 | 19706201 | ||
| Pubmed | 8.26e-07 | 24 | 106 | 4 | 18945465 | ||
| Pubmed | Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation. | 8.26e-07 | 24 | 106 | 4 | 15489916 | |
| Pubmed | Editorial. Nef: a notorious enigmatic factor in HIV biology. | 8.26e-07 | 24 | 106 | 4 | 22175768 | |
| Pubmed | 9.81e-07 | 25 | 106 | 4 | 16091223 | ||
| Pubmed | 1.16e-06 | 26 | 106 | 4 | 11827988 | ||
| Pubmed | Interactions of viral protein U (Vpu) with cellular factors. | 1.36e-06 | 27 | 106 | 4 | 20012522 | |
| Pubmed | 1.36e-06 | 27 | 106 | 4 | 12836198 | ||
| Pubmed | Keeping the (kinase) party going: SLP-76 and ITK dance to the beat. | 1.58e-06 | 28 | 106 | 4 | 17652306 | |
| Pubmed | One protein to rule them all: modulation of cell surface receptors and molecules by HIV Nef. | 1.58e-06 | 28 | 106 | 4 | 22103833 | |
| Pubmed | 1.83e-06 | 29 | 106 | 4 | 15078178 | ||
| Pubmed | 2.10e-06 | 30 | 106 | 4 | 16454711 | ||
| Pubmed | Misdirection of membrane trafficking by HIV-1 Vpu and Nef: Keys to viral virulence and persistence. | 2.41e-06 | 31 | 106 | 4 | 21922073 | |
| Pubmed | 2.41e-06 | 31 | 106 | 4 | 11048639 | ||
| Pubmed | 2.74e-06 | 32 | 106 | 4 | 19449444 | ||
| Pubmed | Roles of HIV-1 auxiliary proteins in viral pathogenesis and host-pathogen interactions. | 3.12e-06 | 33 | 106 | 4 | 16354571 | |
| Pubmed | 4.46e-06 | 11 | 106 | 3 | 20668555 | ||
| Pubmed | 5.93e-06 | 12 | 106 | 3 | 12736707 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 22737229 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 21346778 | ||
| Pubmed | Analysis of H2-O influence on antigen presentation by B cells. | 9.20e-06 | 2 | 106 | 2 | 12928379 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 25863099 | ||
| Pubmed | Genome-wide association study of aspirin-exacerbated respiratory disease in a Korean population. | 9.20e-06 | 2 | 106 | 2 | 23180272 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 11927536 | ||
| Pubmed | The genomic organisation and nucleotide sequence of the HLA-SB(DP) alpha gene. | 9.20e-06 | 2 | 106 | 2 | 2997750 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 15304007 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 24846544 | ||
| Pubmed | Predicting HLA alleles from high-resolution SNP data in three Southeast Asian populations. | 9.20e-06 | 2 | 106 | 2 | 24698974 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 22923493 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 29283185 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 19349983 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 10958363 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 20376809 | ||
| Pubmed | H2-O influence on antigen presentation in H2-E-expressing mice. | 9.20e-06 | 2 | 106 | 2 | 12884868 | |
| Pubmed | Allele and haplotype frequencies of HLA-DPA1 and -DPB1 in the population of Guadeloupe. | 9.20e-06 | 2 | 106 | 2 | 24405442 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 6325928 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 21274863 | ||
| Pubmed | Host genetic factors affecting spontaneous HBsAg seroclearance in chronic hepatitis B patients. | 9.20e-06 | 2 | 106 | 2 | 23326374 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 20424227 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 24897020 | ||
| Pubmed | Four new DP alleles identified in a study of 500 unrelated bone marrow donor-recipient pairs. | 9.20e-06 | 2 | 106 | 2 | 10090623 | |
| Pubmed | FBXL14 abolishes breast cancer progression by targeting CDCP1 for proteasomal degradation. | 9.20e-06 | 2 | 106 | 2 | 29973690 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 15603877 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 27051043 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 25020231 | ||
| Pubmed | pH-susceptibility of HLA-DO tunes DO/DM ratios to regulate HLA-DM catalytic activity. | 9.20e-06 | 2 | 106 | 2 | 26610428 | |
| Pubmed | The effect of HLA-DP gene polymorphisms in Plasmodium Vivax-induced malaria susceptibility. | 9.20e-06 | 2 | 106 | 2 | 37980631 | |
| Pubmed | A novel variant marking HLA-DP expression levels predicts recovery from hepatitis B virus infection. | 9.20e-06 | 2 | 106 | 2 | 22496224 | |
| Pubmed | Response to hepatitis B vaccination is co-determined by HLA-DPA1 and -DPB1. | 9.20e-06 | 2 | 106 | 2 | 31515149 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 24465836 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 17475805 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 11556979 | ||
| Pubmed | Systematic protein-protein interaction mapping for clinically relevant human GPCRs. | SPNS1 TMEM42 PRSS16 SLC4A3 TMBIM1 VAC14 NRXN3 SCARB1 TSPAN4 SERINC5 SLC52A2 | 9.60e-06 | 697 | 106 | 11 | 28298427 |
| Pubmed | A mouse knockout library for secreted and transmembrane proteins. | CRISPLD2 PRSS22 SLC2A14 FXYD4 MUC16 CDCP1 SIGLEC10 SLC49A3 ADGRF3 | 1.21e-05 | 460 | 106 | 9 | 20562862 |
| Pubmed | Strategies for inhibiting function of HIV-1 accessory proteins: a necessary route to AIDS therapy? | 1.31e-05 | 47 | 106 | 4 | 19149577 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 23449268 | ||
| Pubmed | Cloning genes encoding receptors related to chemoattractant receptors. | 2.76e-05 | 3 | 106 | 2 | 9653656 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 17060025 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 3036829 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 21814517 | ||
| Pubmed | Ectopic expression of HLA-DO in mouse dendritic cells diminishes MHC class II antigen presentation. | 2.76e-05 | 3 | 106 | 2 | 15265882 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 2987832 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 34484213 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 25030943 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 8649448 | ||
| Interaction | SLC35B2 interactions | 4.52e-06 | 92 | 94 | 6 | int:SLC35B2 | |
| Interaction | C3orf52 interactions | PDE3B SLC39A2 RMDN3 KIDINS220 SLC12A9 SLC16A2 ATP13A3 TMEM223 CLEC10A | 1.28e-05 | 305 | 94 | 9 | int:C3orf52 |
| Interaction | HLA-DPA1 interactions | 2.09e-05 | 120 | 94 | 6 | int:HLA-DPA1 | |
| Interaction | SEC22A interactions | 3.14e-05 | 129 | 94 | 6 | int:SEC22A | |
| Interaction | HAVCR2 interactions | 4.32e-05 | 83 | 94 | 5 | int:HAVCR2 | |
| Interaction | LHFPL5 interactions | 5.39e-05 | 142 | 94 | 6 | int:LHFPL5 | |
| Interaction | SLC22A18 interactions | 5.71e-05 | 45 | 94 | 4 | int:SLC22A18 | |
| Cytoband | 17q24 | 1.42e-06 | 10 | 106 | 3 | 17q24 | |
| Cytoband | 6p21.3 | 2.98e-04 | 250 | 106 | 5 | 6p21.3 | |
| GeneFamily | Solute carriers | SLC39A2 SLC26A4 SLC35C2 SLC2A14 SLC1A2 SLC4A3 SLC22A18 SLC9B1 SLC9A4 SLC8B1 SLC9A5 SLC12A9 SLC16A2 SLC35G3 SLC49A3 SLC52A2 SLC39A5 SLC27A5 | 7.13e-14 | 395 | 79 | 18 | 752 |
| GeneFamily | Calcium voltage-gated channel subunits | 8.58e-08 | 26 | 79 | 5 | 253 | |
| GeneFamily | Claudins | 2.81e-06 | 23 | 79 | 4 | 488 | |
| GeneFamily | C1-set domain containing | 3.33e-05 | 42 | 79 | 4 | 591 | |
| GeneFamily | Histocompatibility complex|C1-set domain containing | 4.01e-05 | 44 | 79 | 4 | 588 | |
| GeneFamily | G protein-coupled receptors, Class A orphans | 3.77e-04 | 78 | 79 | 4 | 262 | |
| GeneFamily | Ubiquitin like modifier activating enzymes | 8.29e-04 | 10 | 79 | 2 | 100 | |
| GeneFamily | F-box and leucine rich repeat proteins | 3.75e-03 | 21 | 79 | 2 | 558 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 5.66e-03 | 163 | 79 | 4 | 590 | |
| Coexpression | VERHAAK_AML_WITH_NPM1_MUTATED_DN | PDE3B HLA-DPA1 HLA-DPB1 CLDN15 CD7 LHFPL2 SERINC5 LTF CLEC10A | 7.07e-07 | 250 | 104 | 9 | M10117 |
| Coexpression | DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_MACROPHAGES | 7.99e-07 | 80 | 104 | 6 | M39282 | |
| Coexpression | TRAVAGLINI_LUNG_TREM2_DENDRITIC_CELL | HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 TMBIM1 HAVCR2 RMDN3 TSPAN4 LHFPL2 SLC49A3 CLEC10A GNS | 2.90e-06 | 572 | 104 | 12 | M41698 |
| Coexpression | TRAVAGLINI_LUNG_EREG_DENDRITIC_CELL | LST1 HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 CDCP1 HAVCR2 CSF2RA LHFPL2 ATP13A3 CLEC10A GNS | 3.17e-06 | 577 | 104 | 12 | M41697 |
| Coexpression | DESCARTES_FETAL_INTESTINE_MYELOID_CELLS | HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 CSF2RA SIGLEC10 CMKLR1 CLEC10A | 3.89e-06 | 230 | 104 | 8 | M40210 |
| Coexpression | DESCARTES_FETAL_LUNG_MYELOID_CELLS | 7.22e-06 | 178 | 104 | 7 | M40244 | |
| Coexpression | DESCARTES_FETAL_ADRENAL_MYELOID_CELLS | 9.29e-06 | 185 | 104 | 7 | M40148 | |
| Coexpression | DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_MONOCYTES | 1.56e-05 | 38 | 104 | 4 | M39297 | |
| Coexpression | DESCARTES_FETAL_PLACENTA_MYELOID_CELLS | 2.61e-05 | 146 | 104 | 6 | M40285 | |
| Coexpression | BUSSLINGER_GASTRIC_REG3A_POSITIVE_CELLS | 2.81e-05 | 44 | 104 | 4 | M40016 | |
| Coexpression | DESCARTES_FETAL_PANCREAS_ACINAR_CELLS | 3.00e-05 | 90 | 104 | 5 | M40267 | |
| Coexpression | GAO_LARGE_INTESTINE_24W_C11_PANETH_LIKE_CELL | 4.60e-05 | 324 | 104 | 8 | M39160 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN | 5.74e-05 | 103 | 104 | 5 | MM476 | |
| Coexpression | AIZARANI_LIVER_C25_KUPFFER_CELLS_4 | 6.96e-05 | 174 | 104 | 6 | M39126 | |
| Coexpression | FAN_OVARY_CL13_MONOCYTE_MACROPHAGE | LST1 SPNS1 HLA-DMA HLA-DPA1 HLA-DPB1 HAVCR2 CSF2RA ATP13A3 CLEC10A | 8.90e-05 | 458 | 104 | 9 | M41715 |
| Coexpression | LI_PBMC_MENACTRA_AGE_18_45YO_CORRELATED_WITH_ANTI_POLYSACCHARIDE_ANTIBODY_3DY_POSITIVE | 9.61e-05 | 60 | 104 | 4 | M40971 | |
| Coexpression | WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN | 1.31e-04 | 25 | 104 | 3 | M18519 | |
| Coexpression | GSE3982_CTRL_VS_PMA_STIM_EOSINOPHIL_UP | 1.38e-04 | 197 | 104 | 6 | M5363 | |
| Coexpression | GSE36826_WT_VS_IL1R_KO_SKIN_UP | 1.38e-04 | 197 | 104 | 6 | M9537 | |
| Coexpression | HAY_BONE_MARROW_DENDRITIC_CELL | 1.38e-04 | 197 | 104 | 6 | M39194 | |
| Coexpression | GSE36826_NORMAL_VS_STAPH_AUREUS_INF_IL1R_KO_SKIN_UP | 1.45e-04 | 199 | 104 | 6 | M9531 | |
| Coexpression | GSE24634_TEFF_VS_TCONV_DAY7_IN_CULTURE_DN | 1.49e-04 | 200 | 104 | 6 | M4624 | |
| Coexpression | AIZARANI_LIVER_C2_KUPFFER_CELLS_1 | 1.49e-04 | 200 | 104 | 6 | M39106 | |
| Coexpression | GSE10325_CD4_TCELL_VS_MYELOID_DN | 1.49e-04 | 200 | 104 | 6 | M3079 | |
| Coexpression | GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_IL23A_TREATED_CD4_TCELL_UP | 1.49e-04 | 200 | 104 | 6 | M5627 | |
| Coexpression | DESCARTES_FETAL_MUSCLE_MYELOID_CELLS | 1.72e-04 | 130 | 104 | 5 | M40259 | |
| Coexpression | FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_DN | SPNS1 TDRD9 SLC2A14 UNC45A ABCC6 SLC22A18 SLC9B1 AKR7A3 DISP3 ADGRF3 LTF | 1.86e-04 | 746 | 104 | 11 | M40863 |
| Coexpression | GAURNIER_PSMD4_TARGETS | 2.06e-04 | 73 | 104 | 4 | M11428 | |
| Coexpression | BUSSLINGER_ESOPHAGEAL_DENDRITIC_CELLS | 2.15e-04 | 214 | 104 | 6 | M40005 | |
| Coexpression | DESCARTES_FETAL_STOMACH_MYELOID_CELLS | 2.41e-04 | 76 | 104 | 4 | M40302 | |
| CoexpressionAtlas | Myeloid Cells, Mo.6C-II+.Bl, CD115+ B220- CD43+ Ly6C- MHCIIhi, Blood, avg-2 | LST1 HLA-DMA HLA-DOA HAVCR2 CD7 CSF2RA SCARB1 SIGLEC10 CMKLR1 CLEC10A | 2.32e-05 | 413 | 99 | 10 | GSM605878_500 |
| CoexpressionAtlas | Myeloid Cells, DC.8-4-11b-.Sp, CD45-APC CD11b-FITC CD11c-eFluor780 CD4-PE CD8a-eF, Spleen, avg-2 | 3.63e-05 | 80 | 99 | 5 | GSM605837_100 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-cDC1|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | LST1 HLA-DMA GPR31 HLA-DOA HLA-DPA1 HLA-DPB1 HAVCR2 VAC14 CSF2RA SCARB1 SIGLEC10 | 5.13e-13 | 177 | 106 | 11 | 345cebc19f93970a9a46be139208b300081f5493 |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-Myeloid-cDC1|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | LST1 HLA-DMA GPR31 HLA-DOA HLA-DPA1 HLA-DPB1 HAVCR2 VAC14 CSF2RA SIGLEC10 | 9.98e-12 | 169 | 106 | 10 | da3485d77bb7876fad4f166f6099e681b27457ae |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Myeloid-cDC1|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | HLA-DMA GPR31 HLA-DOA HLA-DPA1 HLA-DPB1 SLC4A3 HAVCR2 VAC14 CSF2RA SIGLEC10 | 1.26e-11 | 173 | 106 | 10 | d13ae4046a25ee0fb492ddedf44583a879a432e9 |
| ToppCell | 3'_v3-GI_small-bowel-Myeloid_Dendritic|GI_small-bowel / Manually curated celltypes from each tissue | LST1 HLA-DMA GPR31 HLA-DOA HLA-DPA1 HLA-DPB1 SLC4A3 CSF2RA SCARB1 SIGLEC10 | 2.20e-11 | 183 | 106 | 10 | 6109199cf25b28831193a5ed7925b5bf38c6eb43 |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Myeloid-cDC1|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | LST1 HLA-DMA GPR31 HLA-DOA HLA-DPA1 HLA-DPB1 HAVCR2 VAC14 CSF2RA SIGLEC10 | 2.72e-11 | 187 | 106 | 10 | 8249b2a69c728e4e04fb14b490c320e644d2252f |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-Macrophages|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | LST1 HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 HAVCR2 CSF2RA SIGLEC10 CMKLR1 CLEC10A | 3.91e-11 | 194 | 106 | 10 | 44a90be1d2b2ae08f8c523bee65dd1e536ec0f95 |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-Myeloid|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | LST1 HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 HAVCR2 CSF2RA SIGLEC10 CMKLR1 CLEC10A | 4.12e-11 | 195 | 106 | 10 | f289a44010788853d7726d4b5aa75f3c62186c08 |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-Myeloid-Macrophages|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | LST1 HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 HAVCR2 CSF2RA SIGLEC10 CMKLR1 CLEC10A | 4.33e-11 | 196 | 106 | 10 | fa24d7c4b7c65e98b209db302a16c58ceac1a105 |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-Macrophages|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | LST1 HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 HAVCR2 CSF2RA SIGLEC10 CMKLR1 CLEC10A | 4.55e-11 | 197 | 106 | 10 | 10190b877bf46ba2163d203df9dd3b498c66e52f |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | LST1 HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 HAVCR2 CSF2RA SIGLEC10 CMKLR1 CLEC10A | 4.79e-11 | 198 | 106 | 10 | dbae6a58cb3ce8612755fbdba6194b70b35f258a |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | LST1 HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 HAVCR2 CSF2RA SIGLEC10 CMKLR1 CLEC10A | 5.03e-11 | 199 | 106 | 10 | f34c15df58fbdc6c90e30800e26fabbf828ad10b |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | LST1 HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 HAVCR2 CSF2RA SIGLEC10 CMKLR1 CLEC10A | 5.03e-11 | 199 | 106 | 10 | 5ceeed92f831d068ff4bb3994f420002338330e7 |
| ToppCell | cellseq-Immune-Immune_Myeloid-IM|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 HAVCR2 CSF2RA SIGLEC10 LHFPL2 CMKLR1 CLEC10A | 5.03e-11 | 199 | 106 | 10 | b3267d5a7ae0461f5e9e6a3ab6783317a8c42506 |
| ToppCell | cellseq-Immune-Immune_Myeloid-IM-IM|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 HAVCR2 CSF2RA SIGLEC10 LHFPL2 CMKLR1 CLEC10A | 5.03e-11 | 199 | 106 | 10 | 01dacee8bb392639d475be3cb27ba3eeff1e57f1 |
| ToppCell | mild-cDC|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | TMEM61 HLA-DMA GPR31 HLA-DOA HLA-DPA1 HLA-DPB1 SLC4A3 HAVCR2 CSF2RA CLEC10A | 5.28e-11 | 200 | 106 | 10 | 86f585bf9066b179bbcbc703bf43f15da4a07284 |
| ToppCell | ICU-NoSEP-Myeloid-cDC2|ICU-NoSEP / Disease, Lineage and Cell Type | HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 CDCP1 SLC4A3 HAVCR2 CSF2RA CLEC10A | 2.60e-10 | 167 | 106 | 9 | 5b7b731944d888591279ef6167b3ae8cab3f6886 |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_dendritic|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | LST1 HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 CDCP1 SLC4A3 ATP13A3 CLEC10A | 2.60e-10 | 167 | 106 | 9 | ecdbfde870a2a44c44b9dd65a8737afc6fbf816c |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Hematopoietic-Myeloid-Macrophages|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | LST1 HLA-DMA HLA-DPA1 HLA-DPB1 HAVCR2 CSF2RA SIGLEC10 CMKLR1 CLEC10A | 3.94e-10 | 175 | 106 | 9 | fe27c3279f660b5be4193005394b77163c599d32 |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-Myeloid-cDC1|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | LST1 HLA-DMA GPR31 HLA-DPA1 HLA-DPB1 HAVCR2 VAC14 CSF2RA SIGLEC10 | 5.85e-10 | 183 | 106 | 9 | 8542040b7585842b89bb1329dae4029c1b7b5427 |
| ToppCell | 3'_v3-GI_small-bowel-Myeloid_Dendritic-DC1|GI_small-bowel / Manually curated celltypes from each tissue | HLA-DMA GPR31 HLA-DOA HLA-DPA1 HLA-DPB1 VAC14 CSF2RA SCARB1 SIGLEC10 | 6.14e-10 | 184 | 106 | 9 | 8e393eea7240584a3cef718bee094e2705ec1891 |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | LST1 HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 CD7 CSF2RA SIGLEC10 CLEC10A | 6.44e-10 | 185 | 106 | 9 | e592c27f711d13bfc6546893acaab4c8600b0be1 |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Myeloid-cDC2|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | LST1 HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 HAVCR2 CSF2RA SIGLEC10 CLEC10A | 6.75e-10 | 186 | 106 | 9 | 69b107ad88b07e9aeef09d4e4dac99b0cb6b467e |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | LST1 HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 HAVCR2 CSF2RA SIGLEC10 CLEC10A | 6.75e-10 | 186 | 106 | 9 | bec4767eaca28e41da373274704895eba75063e2 |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | LST1 HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 HAVCR2 CSF2RA SIGLEC10 CLEC10A | 7.42e-10 | 188 | 106 | 9 | c7c2cf1aa328e735073d6031e44b5dbd55beae6d |
| ToppCell | 3'-Adult-LargeIntestine-Hematopoietic-Myeloid-cDC2|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | LST1 HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 HAVCR2 CSF2RA SIGLEC10 CLEC10A | 7.78e-10 | 189 | 106 | 9 | 8419d62e6991851bdc6ad861f5c9086ff808b222 |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_5|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 CDCP1 SLC4A3 HAVCR2 CSF2RA CLEC10A | 7.78e-10 | 189 | 106 | 9 | c81b38cda4525254fe4fa137a4c9bc9abe0363bb |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_5|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 CDCP1 SLC4A3 HAVCR2 CSF2RA CLEC10A | 7.78e-10 | 189 | 106 | 9 | 807922b5ea0faddd3abfa9ec1b53f3f2b00e61bf |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Myeloid-Macrophages|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | LST1 HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 CSF2RA SIGLEC10 CMKLR1 CLEC10A | 8.54e-10 | 191 | 106 | 9 | 94c7da03e5264f4d73bb507ce339a935d90279a0 |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-Myeloid-cDC1|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | LST1 HLA-DMA GPR31 HLA-DOA HLA-DPA1 HLA-DPB1 HAVCR2 CSF2RA SIGLEC10 | 8.54e-10 | 191 | 106 | 9 | 9774d423e448ec2d415261e4ad386a81558129b3 |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-Myeloid-cDC2|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | LST1 HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 HAVCR2 CSF2RA SIGLEC10 CLEC10A | 8.94e-10 | 192 | 106 | 9 | 90274b85f3d612b6a6d435860cd6d049ddeb1d96 |
| ToppCell | 367C-Myeloid-Dendritic|367C / Donor, Lineage, Cell class and subclass (all cells) | LST1 HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 HAVCR2 CSF2RA SIGLEC10 CLEC10A | 9.36e-10 | 193 | 106 | 9 | 365e831ae6ac67fb36d8d70ef139f4ae7e32c83f |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-Myeloid-Macrophages|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | LST1 HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 CSF2RA SIGLEC10 CMKLR1 CLEC10A | 9.79e-10 | 194 | 106 | 9 | 7c7091de47359760003e910cfbe63db5c99410d6 |
| ToppCell | cellseq-Immune-Immune_Myeloid-Myeloid_Dendritic-cDC2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | LST1 HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 HAVCR2 CSF2RA SIGLEC10 CLEC10A | 9.79e-10 | 194 | 106 | 9 | 024568d8a862f0fe4da1f66a58c6e71f0e8279f3 |
| ToppCell | Monocytes-C1QA+_Monocytes|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | LST1 HLA-DMA HLA-DPA1 HLA-DPB1 CDCP1 HAVCR2 CSF2RA CMKLR1 CLEC10A | 9.79e-10 | 194 | 106 | 9 | 3e104e85574894c04791252d466d438fc809dde3 |
| ToppCell | 18-Airway-Immune-Hematopoietic,_Macrophage|Airway / Age, Tissue, Lineage and Cell class | LST1 HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 HAVCR2 CSF2RA SIGLEC10 CLEC10A | 9.79e-10 | 194 | 106 | 9 | 9671fed8cd45ea8c7a411239aa5012c2a1edf264 |
| ToppCell | cellseq-Immune-Immune_Myeloid-Myeloid_Dendritic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | LST1 HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 HAVCR2 CSF2RA SIGLEC10 CLEC10A | 9.79e-10 | 194 | 106 | 9 | 74d588de2f84a4ef112fd642f7e112a542d5ef11 |
| ToppCell | 15-Airway-Immune-Hematopoietic,_Macrophage|Airway / Age, Tissue, Lineage and Cell class | LST1 HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 HAVCR2 CSF2RA SIGLEC10 CLEC10A | 1.02e-09 | 195 | 106 | 9 | 705aa5442c61d5fdc0aafb2ad40b8c9d2dc566c6 |
| ToppCell | 15-Trachea-Immune-Hematopoietic,_Macrophage|Trachea / Age, Tissue, Lineage and Cell class | LST1 HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 HAVCR2 CSF2RA SIGLEC10 CLEC10A | 1.02e-09 | 195 | 106 | 9 | 495453b3cf08fa3c5d37ad3a2bf9c526118f9600 |
| ToppCell | Monocytes|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | LST1 HLA-DMA HLA-DPA1 HLA-DPB1 CDCP1 HAVCR2 CSF2RA SCARB1 CLEC10A | 1.07e-09 | 196 | 106 | 9 | ab0a8f5f388c9794d7f41f99fb0a5f2fd6fff6b3 |
| ToppCell | 10x5'-GI_small-bowel-Myeloid_Dendritic|GI_small-bowel / Manually curated celltypes from each tissue | LST1 HLA-DMA GPR31 HLA-DOA HLA-DPA1 HLA-DPB1 SLC4A3 CSF2RA CLEC10A | 1.07e-09 | 196 | 106 | 9 | 571fade4d65427d277b7d37446b289ea5ebb8635 |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | LST1 HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 HAVCR2 CSF2RA SIGLEC10 CLEC10A | 1.07e-09 | 196 | 106 | 9 | f667430a61bc962e4d033818a05348bf40762041 |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | LST1 HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 HAVCR2 CSF2RA SIGLEC10 CLEC10A | 1.07e-09 | 196 | 106 | 9 | a692cee9254f3771a076b290688a4d0120c02c3b |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | LST1 HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 HAVCR2 CSF2RA SIGLEC10 CLEC10A | 1.12e-09 | 197 | 106 | 9 | 09a2c0c0f9c2442743414236c2d5c1f27be66e4c |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Myeloid-Macrophages|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | LST1 HLA-DMA HLA-DPA1 HLA-DPB1 HAVCR2 CSF2RA SIGLEC10 CMKLR1 CLEC10A | 1.12e-09 | 197 | 106 | 9 | e698a0bbb20bd4868ff4348f2ac9f609942b55fa |
| ToppCell | Monocytes-cDCs|World / Immune cells in Kidney/Urine in Lupus Nephritis | LST1 HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 SLC4A3 CSF2RA SLC12A9 CLEC10A | 1.12e-09 | 197 | 106 | 9 | 3388c104af4c6a05988e102627e0c5e34d9dcc45 |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Dendritic_cell-DC_1|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | LST1 HLA-DMA GPR31 HLA-DOA HLA-DPA1 HLA-DPB1 SLC4A3 CSF2RA SIGLEC10 | 1.12e-09 | 197 | 106 | 9 | 81dd7f9318f0ba175352e5156c24772427e0b34f |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | LST1 HLA-DMA HLA-DPA1 HLA-DPB1 HAVCR2 CSF2RA SIGLEC10 CMKLR1 CLEC10A | 1.17e-09 | 198 | 106 | 9 | 79c8ab15e73f727c5e110ab9eab3ccb5edf9f714 |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid-Macrophages|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | LST1 HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 CSF2RA SIGLEC10 CMKLR1 CLEC10A | 1.17e-09 | 198 | 106 | 9 | 88635244a0b306d2cc50b8412fe47bb359c9cf00 |
| ToppCell | distal-Hematologic-Interstitial_Macrophage|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | LST1 HLA-DMA HLA-DOA HAVCR2 CSF2RA SIGLEC10 LHFPL2 CMKLR1 CLEC10A | 1.17e-09 | 198 | 106 | 9 | a35b43d38e18c6f8f0cd9015b8e23f71c729f023 |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Dendritic_cell-DC_2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | LST1 HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 HAVCR2 CSF2RA SIGLEC10 CLEC10A | 1.17e-09 | 198 | 106 | 9 | 25b40926412a15ca91f30cd57a547a60396e9dd3 |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | LST1 HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 CD7 CSF2RA SIGLEC10 CLEC10A | 1.17e-09 | 198 | 106 | 9 | 41e8a7894f52f3a5f8f24575b3f6e205429489b2 |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-Myeloid|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | LST1 HLA-DMA HLA-DPA1 HLA-DPB1 HAVCR2 CSF2RA SIGLEC10 CMKLR1 CLEC10A | 1.17e-09 | 198 | 106 | 9 | be038619157aeaa7a57ebd66392de940df4f8127 |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | LST1 HLA-DMA HLA-DPA1 HLA-DPB1 HAVCR2 CD7 CSF2RA SIGLEC10 CLEC10A | 1.17e-09 | 198 | 106 | 9 | 23314bed02edadccdc5da4fa153142a25e4a440e |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular-Interstitial_macrophage_perivascular_L.1.2.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | LST1 HLA-DMA HLA-DPA1 HLA-DPB1 HAVCR2 CSF2RA LHFPL2 CMKLR1 CLEC10A | 1.23e-09 | 199 | 106 | 9 | 4e552015989defc32fe9068e0ba28521b2a1a09c |
| ToppCell | 3'_v3-GI_small-bowel-Myeloid_Mac|GI_small-bowel / Manually curated celltypes from each tissue | LST1 HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 CSF2RA LHFPL2 CMKLR1 CLEC10A | 1.23e-09 | 199 | 106 | 9 | 8990a3d69e24cb3aaba9d6def3d0be9ee973436d |
| ToppCell | 3'_v3-GI_small-bowel-Myeloid_Mac-Intestinal_macrophages|GI_small-bowel / Manually curated celltypes from each tissue | LST1 HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 CSF2RA LHFPL2 CMKLR1 CLEC10A | 1.23e-09 | 199 | 106 | 9 | 96070b5ffcbab4952970f43b536969ddd2ca5d14 |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-Macrophages|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | LST1 HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 CSF2RA SIGLEC10 CMKLR1 CLEC10A | 1.23e-09 | 199 | 106 | 9 | 9df2c79904dacf029ec9df1f1cde72d871189a82 |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-lung_macrophage|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | LST1 HLA-DMA HLA-DPA1 HLA-DPB1 HAVCR2 CSF2RA LHFPL2 CMKLR1 CLEC10A | 1.23e-09 | 199 | 106 | 9 | 42d57522aa05892f37790d0039d936e065565359 |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | LST1 HLA-DMA HLA-DPA1 HLA-DPB1 HAVCR2 CSF2RA LHFPL2 CMKLR1 CLEC10A | 1.23e-09 | 199 | 106 | 9 | 0554f41ae53c275c92fe692bd999d7578d244fce |
| ToppCell | Biopsy_IPF-Immune-cDCs|Biopsy_IPF / Sample group, Lineage and Cell type | LST1 HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 HAVCR2 CSF2RA SIGLEC10 CLEC10A | 1.28e-09 | 200 | 106 | 9 | f7730e2d3ed14a86141491fd20e3aa562670c757 |
| ToppCell | Transverse-(5)_Dendritic_cell-(50)_cDC2|Transverse / shred on region, Cell_type, and subtype | LST1 HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 GPR162 SLC4A3 CSF2RA CLEC10A | 1.28e-09 | 200 | 106 | 9 | eea523f7512b54d7443651bce3ff6d043a9897aa |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | LST1 HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 CSF2RA SIGLEC10 CMKLR1 CLEC10A | 1.28e-09 | 200 | 106 | 9 | 4b4df0fe47498310d94448b8a289e58e4f5b5aa8 |
| ToppCell | Transverse-Dendritic_cell-cDC2|Transverse / Region, Cell class and subclass | LST1 HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 GPR162 SLC4A3 CSF2RA CLEC10A | 1.28e-09 | 200 | 106 | 9 | 80730a6372627543b84d8fb1b94c481db17c6500 |
| ToppCell | Parenchyma_Control_(B.)-Immune-TX-MoAM-2|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | HLA-DMA HLA-DPA1 HLA-DPB1 HAVCR2 CSF2RA SIGLEC10 LHFPL2 CMKLR1 CLEC10A | 1.28e-09 | 200 | 106 | 9 | 670ef1e68be0d2c6ea20ab4dea1d051a3cc89799 |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | LST1 HLA-DMA HLA-DOA HAVCR2 CSF2RA SIGLEC10 LHFPL2 CMKLR1 CLEC10A | 1.28e-09 | 200 | 106 | 9 | c210b98a75ab5d899d7278bc9b577f76a0b3970c |
| ToppCell | Transverse-Dendritic_cell|Transverse / Region, Cell class and subclass | LST1 HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 GPR162 CSF2RA SIGLEC10 CLEC10A | 1.28e-09 | 200 | 106 | 9 | b0e9eaf0e57e53645e272e2cea9f09bfcfe12a9b |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Macrophage_other|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | LST1 HLA-DMA HLA-DOA HAVCR2 CSF2RA SIGLEC10 LHFPL2 CMKLR1 CLEC10A | 1.28e-09 | 200 | 106 | 9 | 3cfb28299a55fc1c150262a7333c59a48ae65ad1 |
| ToppCell | Transverse-(5)_Dendritic_cell|Transverse / shred on region, Cell_type, and subtype | LST1 HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 GPR162 CSF2RA SIGLEC10 CLEC10A | 1.28e-09 | 200 | 106 | 9 | 6c32a64f7c38818b93eec1e2d41067e5dbd90541 |
| ToppCell | Biopsy_Other_PF-Immune-cDCs|Biopsy_Other_PF / Sample group, Lineage and Cell type | LST1 HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 HAVCR2 CSF2RA SIGLEC10 CLEC10A | 1.28e-09 | 200 | 106 | 9 | 8e455f685f0a9c63e83d6d339d7767f0e9841c6e |
| ToppCell | Bronchus_Control_(B.)-Immune-TX-DCs|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | LST1 HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 HAVCR2 CSF2RA SIGLEC10 CLEC10A | 1.28e-09 | 200 | 106 | 9 | e0beacb88bbdc353a3e883171613027feafcf1ef |
| ToppCell | 15-Distal-Immune|Distal / Age, Tissue, Lineage and Cell class | LST1 HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 HAVCR2 CD7 CSF2RA CLEC10A | 1.28e-09 | 200 | 106 | 9 | b7083124869791280a2235f484f3659a91dd3600 |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Dendritic_cell|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | LST1 HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 HAVCR2 CSF2RA SIGLEC10 CLEC10A | 1.28e-09 | 200 | 106 | 9 | 0cb6e65f9efe1d4fd18b8ef4333cc39956cafdad |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | LST1 HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 CSF2RA SIGLEC10 CLEC10A | 6.43e-09 | 166 | 106 | 8 | 83d0c26ccee605df6b04bbca31661bf4ff4f22ba |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | HLA-DMA GPR31 HLA-DOA HLA-DPA1 HLA-DPB1 SLC4A3 CSF2RA CLEC10A | 6.43e-09 | 166 | 106 | 8 | d373f1092e85eeb317a7406032b259f11e6adbe0 |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | HLA-DMA GPR31 HLA-DOA HLA-DPA1 HLA-DPB1 SLC4A3 CSF2RA CLEC10A | 6.43e-09 | 166 | 106 | 8 | f453a1d545d59003d98485ac31e85e6cf451817c |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-Myeloid-cDC1|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.40e-09 | 169 | 106 | 8 | 4de0c60f3c163b7823f739ebda4e0afc68346628 | |
| ToppCell | Dendritic_Cells-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | HLA-DMA HLA-DOA HLA-DPA1 HAVCR2 WDR74 CSF2RA SIGLEC10 CLEC10A | 9.73e-09 | 175 | 106 | 8 | 584290a51f9975782a5ac8c6ad67c778d8323f8c |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Dendritic-DC2|lymph-node_spleen / Manually curated celltypes from each tissue | LST1 HLA-DMA HLA-DPA1 HLA-DPB1 SLC4A3 CSF2RA SIGLEC10 CLEC10A | 1.02e-08 | 176 | 106 | 8 | 72a3bbab0540ae3e3c94b9573cdb9298a024dbc4 |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | LST1 HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 HAVCR2 CSF2RA CLEC10A | 1.11e-08 | 178 | 106 | 8 | 8184a2b9872f7ca12a9823535de485e841aeffb1 |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_macrophage-stroma-monocytoid_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.11e-08 | 178 | 106 | 8 | e44b0aa82890ae84fc4d1343f1c65ae2fda69a11 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-Myeloid-cDC2|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.11e-08 | 178 | 106 | 8 | 32120936a524c38e621bd2fca17524fef74422e0 | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_DC-DC-tDC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.21e-08 | 180 | 106 | 8 | 3d9f3e6f13e558279b4ef43e2c44c7c50d761745 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-Myeloid-Macrophages|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | LST1 HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 CSF2RA CMKLR1 CLEC10A | 1.21e-08 | 180 | 106 | 8 | 7af90f0e7ca001bf1fe5c860ee54c4cc8eb483bf |
| ToppCell | 390C-Myeloid-Dendritic-cDC1|390C / Donor, Lineage, Cell class and subclass (all cells) | HLA-DMA GPR31 HLA-DOA HLA-DPA1 HLA-DPB1 VAC14 CSF2RA SIGLEC10 | 1.27e-08 | 181 | 106 | 8 | d1c69171600b2d2aec96fa86fa757b588c265f7c |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Dendritic-DC2|bone_marrow / Manually curated celltypes from each tissue | LST1 HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 SLC4A3 CSF2RA CLEC10A | 1.38e-08 | 183 | 106 | 8 | f482e4fe011fa450a475034b1e25587233855bdb |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-Myeloid-Macrophages|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | LST1 HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 CSF2RA CMKLR1 CLEC10A | 1.38e-08 | 183 | 106 | 8 | 92d5a61b57851090eba558f19e2a7010043eff81 |
| ToppCell | tumor_Lung-Myeloid_cells-CD141+_DCs|tumor_Lung / Location, Cell class and cell subclass | 1.44e-08 | 184 | 106 | 8 | f5cad8eb358898ae536cd7a7b37d3ce19528b801 | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_dendritic-im_conventional_dendritic_(19)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | LST1 HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 HAVCR2 CSF2RA SIGLEC10 | 1.44e-08 | 184 | 106 | 8 | 315bb14e848d8e8e4533122047df6f9b89b89d99 |
| ToppCell | 10x5'-GI_small-bowel-Myeloid_Dendritic-DC2|GI_small-bowel / Manually curated celltypes from each tissue | LST1 HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 SLC4A3 CSF2RA CLEC10A | 1.50e-08 | 185 | 106 | 8 | f78be85dd6e443abb7af20f98ff351c1131ece4d |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell-DC2_(CD1c+_dendritic_cell)-DC2_L.1.2.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | LST1 HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 HAVCR2 CSF2RA CLEC10A | 1.57e-08 | 186 | 106 | 8 | 0c55248b4a9f9bcc32a7e94329aea80796fd4a38 |
| ToppCell | wk_08-11-Hematologic-Myeloid-Cycling_DC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | LST1 HLA-DMA HLA-DPA1 HLA-DPB1 HAVCR2 CSF2RA SIGLEC10 CLEC10A | 1.57e-08 | 186 | 106 | 8 | de1f0bc5dbf6dc0e716f5ebbf2bbcfe249811c54 |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell-DC2_(CD1c+_dendritic_cell)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | LST1 HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 HAVCR2 CSF2RA CLEC10A | 1.57e-08 | 186 | 106 | 8 | 5d1d77825b85f80de20d7b91418820c6dbdab84a |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | LST1 HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 HAVCR2 CSF2RA CLEC10A | 1.57e-08 | 186 | 106 | 8 | 61b5300f2d9b02e4c850642e4cae3648af46772f |
| ToppCell | wk_08-11-Hematologic-Myeloid-S100A12-lo_cla._mono.|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | LST1 HLA-DMA HLA-DPA1 HLA-DPB1 HAVCR2 CSF2RA SIGLEC10 CLEC10A | 1.57e-08 | 186 | 106 | 8 | be50f5c7f32b3126442ebff1e7d38aa78b6e4e71 |
| ToppCell | 10x5'-Liver-Myeloid_Dendritic-DC1|Liver / Manually curated celltypes from each tissue | 1.57e-08 | 186 | 106 | 8 | e823529ffd06352c6bdec102f221fdf27f7c7369 | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_DC-DC-DC2|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.70e-08 | 188 | 106 | 8 | 15d8dc514d5da46f6af284e7c1c92c606712dae6 | |
| ToppCell | LAM-Myeloid-DC|LAM / Condition, Lineage and Cell class | LST1 HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 CSF2RA SIGLEC10 CLEC10A | 1.70e-08 | 188 | 106 | 8 | b4140110c2f7d25fd8a0d2749e33e02003ac4bf2 |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Dendritic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | LST1 HLA-DMA HLA-DOA HLA-DPA1 HLA-DPB1 HAVCR2 CSF2RA CLEC10A | 1.70e-08 | 188 | 106 | 8 | 649d27b2ef735b481ec0ed4f7a9b39aacc472a78 |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-conventional_dendritic_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.70e-08 | 188 | 106 | 8 | c39083b8020ae507246959abbb299d78bcd14042 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-conventional_dendritic_cell-DC1_(conventional_dendritic_cell)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.70e-08 | 188 | 106 | 8 | 6e7a678474715f035cc13a0e226a937688f54121 | |
| Drug | isovalerate | 3.99e-06 | 143 | 103 | 7 | CID000010430 | |
| Drug | Cinildipine | 5.46e-06 | 56 | 103 | 5 | CID000002752 | |
| Drug | isradipine | 6.25e-06 | 100 | 103 | 6 | CID000003784 | |
| Drug | nilvadipine | 7.70e-06 | 60 | 103 | 5 | CID000004494 | |
| Drug | lercanidipine | 9.81e-06 | 63 | 103 | 5 | CID000065866 | |
| Drug | mibefradil | 1.06e-05 | 64 | 103 | 5 | CID000060662 | |
| Drug | gallopamil | 1.33e-05 | 67 | 103 | 5 | CID000001234 | |
| Drug | lamotrigine | 1.47e-05 | 116 | 103 | 6 | CID000003878 | |
| Drug | AC1L2AC7 | 1.53e-05 | 69 | 103 | 5 | CID000068733 | |
| Drug | CAS 298-57-7 | 2.02e-05 | 73 | 103 | 5 | CID000002761 | |
| Drug | BCECF | 2.02e-05 | 73 | 103 | 5 | CID004241719 | |
| Drug | ethosuximide | 2.16e-05 | 74 | 103 | 5 | CID000003291 | |
| Drug | bepridil | 2.35e-05 | 126 | 103 | 6 | CID000002351 | |
| Drug | nisoldipine | 2.79e-05 | 78 | 103 | 5 | CID000004499 | |
| Drug | Piribedil hydrochloride [78213-63-5]; Down 200; 12uM; MCF7; HT_HG-U133A | 3.00e-05 | 195 | 103 | 7 | 3512_DN | |
| Drug | AC1NUZ8M | 6.18e-05 | 92 | 103 | 5 | CID000073211 | |
| Drug | phenytoin | 6.27e-05 | 219 | 103 | 7 | CID000001775 | |
| Drug | procaine | 6.98e-05 | 153 | 103 | 6 | CID000004914 | |
| Drug | manidipine | 7.21e-05 | 95 | 103 | 5 | CID000004008 | |
| Disease | Anti-rubella virus IgG measurement | 3.27e-05 | 3 | 98 | 2 | EFO_0009357 | |
| Disease | Aspirin-induced asthma | 3.27e-05 | 3 | 98 | 2 | HP_0012042 | |
| Disease | Anti-hepatitis B virus surface antigen IgG measurement, response to vaccine | 3.27e-05 | 3 | 98 | 2 | EFO_0004645, EFO_0009358 | |
| Disease | occupational asthma (is_implicated_in) | 6.52e-05 | 4 | 98 | 2 | DOID:0080820 (is_implicated_in) | |
| Disease | chronic hepatitis B virus infection | 6.83e-05 | 24 | 98 | 3 | EFO_0004239 | |
| Disease | allergic asthma (is_implicated_in) | 1.08e-04 | 5 | 98 | 2 | DOID:9415 (is_implicated_in) | |
| Disease | nephrolithiasis (implicated_via_orthology) | 1.08e-04 | 5 | 98 | 2 | DOID:585 (implicated_via_orthology) | |
| Disease | extranodal nasal NK/T cell lymphoma | 1.62e-04 | 6 | 98 | 2 | MONDO_0019472 | |
| Disease | Granulomatosis with polyangiitis | 1.62e-04 | 6 | 98 | 2 | C3495801 | |
| Disease | Achalasia | 2.27e-04 | 7 | 98 | 2 | HP_0002571 | |
| Disease | mortality | 2.86e-04 | 173 | 98 | 5 | EFO_0004352 | |
| Disease | postherpetic neuralgia | 3.02e-04 | 8 | 98 | 2 | MONDO_0041052 | |
| Disease | Hepatitis B, Chronic | 3.02e-04 | 8 | 98 | 2 | C0524909 | |
| Disease | hepatitis B virus infection, Susceptibility to viral and mycobacterial infections | 3.02e-04 | 8 | 98 | 2 | EFO_0004197, Orphanet_391311 | |
| Disease | hepatitis A virus cellular receptor 2 measurement | 3.02e-04 | 8 | 98 | 2 | EFO_0008151 | |
| Disease | Dermatitis, Irritant | 3.87e-04 | 9 | 98 | 2 | C0162823 | |
| Disease | C-C motif chemokine 21 measurement | 4.83e-04 | 10 | 98 | 2 | EFO_0008048 | |
| Disease | dermatomyositis | 7.05e-04 | 12 | 98 | 2 | EFO_0000398 | |
| Disease | Granulomatosis with Polyangiitis | 8.32e-04 | 13 | 98 | 2 | EFO_0005297 | |
| Disease | icos ligand measurement | 8.32e-04 | 13 | 98 | 2 | EFO_0020460 | |
| Disease | neuronal ceroid lipofuscinosis (implicated_via_orthology) | 9.68e-04 | 14 | 98 | 2 | DOID:14503 (implicated_via_orthology) | |
| Disease | liver neoplasm | 1.11e-03 | 15 | 98 | 2 | EFO_1001513 | |
| Disease | severe aplastic anemia | 1.11e-03 | 15 | 98 | 2 | EFO_0006927 | |
| Disease | gastroparesis | 1.27e-03 | 16 | 98 | 2 | EFO_1000948 | |
| Disease | susceptibility to hepatitis B infection measurement | 1.28e-03 | 64 | 98 | 3 | EFO_0008405 | |
| Disease | graft-versus-host disease (is_implicated_in) | 1.44e-03 | 17 | 98 | 2 | DOID:0081267 (is_implicated_in) | |
| Disease | theta wave measurement | 1.44e-03 | 17 | 98 | 2 | EFO_0006873 | |
| Disease | rosacea severity measurement | 1.49e-03 | 147 | 98 | 4 | EFO_0009180 | |
| Disease | response to platinum based chemotherapy | 1.61e-03 | 18 | 98 | 2 | EFO_0004647 | |
| Disease | hepatitis B virus infection | 1.80e-03 | 19 | 98 | 2 | EFO_0004197 | |
| Disease | alpha-2-macroglobulin receptor-associated protein measurement | 2.87e-03 | 24 | 98 | 2 | EFO_0008021 | |
| Disease | Autism Spectrum Disorders | 2.88e-03 | 85 | 98 | 3 | C1510586 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VGLLGISKGGELCLS | 226 | Q86TX2 | |
| LDLLLIGSLGGLCGL | 1026 | P48751 | |
| VGLGASILALLVCLG | 776 | Q8IZF5 | |
| GAVLLAGALGLGACL | 1361 | Q9P2K9 | |
| ISFLLGLGLGVACVL | 186 | P09564 | |
| GFLGLLVSGFGLDCL | 91 | A6NM45 | |
| TILGGLGLRLGGSDC | 56 | O95154 | |
| CGVSIALLGVLLLGA | 6 | Q9H5V8 | |
| IVSLGVICSGGFLLL | 31 | Q9H7F0 | |
| AVGVLLGLECGLGLL | 16 | O00270 | |
| FLLGFLGPLAIIGTC | 221 | O75388 | |
| LALGGLLLIFSACLG | 176 | C9JDP6 | |
| CALGLVLGLVGIIVG | 226 | P20036 | |
| TLTGAGGFVLGLIIC | 226 | P04440 | |
| LAGLLVGLLIRCFIG | 236 | O94778 | |
| LRVGAVCFGLSGLLL | 171 | Q9BXT2 | |
| LGCGVGAGLILLLGA | 221 | Q9BXT2 | |
| GAGLILLLGAGCFLL | 226 | Q9BXT2 | |
| GLGCSLLFIPLGLVD | 271 | Q9BV10 | |
| GFIILGSLCVLLSLG | 116 | Q06432 | |
| GGLIVVCLFLGLCDG | 411 | P36021 | |
| PLLLLLVGGAFLGAC | 16 | Q9NZ53 | |
| ILIGLAGLLGVITCL | 14456 | Q8WXI7 | |
| LTLLGNGVIFGIICL | 36 | Q96R47 | |
| IVFLTLLLCGGLGLL | 501 | Q9ULH0 | |
| LLLCGGLGLLFAFTV | 506 | Q9ULH0 | |
| GLFCVLGIVLLVTGI | 221 | Q969X1 | |
| GLGFGVCFSLLLLGG | 176 | Q16538 | |
| GGGCLGTFTSLLLLA | 11 | Q9GZN4 | |
| TGLVGLGLSCLAGQL | 431 | Q8IWD5 | |
| AGGLGAILLLLVCLV | 361 | Q9NZN1 | |
| GCAIQLFLFLGLGGV | 96 | Q7Z3T1 | |
| LFLFLGLGGVECLLL | 101 | Q7Z3T1 | |
| PLLSGLVGGAGCLLA | 246 | Q13370 | |
| GGVIPLGLLFLVCGS | 6 | Q9H0B8 | |
| ILLGSLLGLCLGLEF | 16 | Q9Y4C0 | |
| IGFLLGSCGIALALT | 446 | Q9P265 | |
| CGLLQGIAGLFLILG | 136 | Q6ZUX7 | |
| GLLCFLALGLLGSAG | 6 | Q9BXB1 | |
| VLDLGCGSGLLGITA | 191 | O95568 | |
| GLTGLRLLNLSFCGG | 226 | Q8N1E6 | |
| LGRLVIGLFCGLCTG | 146 | Q8TDB8 | |
| LLGGTALLRCGATGV | 266 | Q9P2V4 | |
| LTLLGNGVIFGIICL | 36 | Q6IF42 | |
| GLILGICAGGLAVLI | 746 | Q92729 | |
| ICAGGLAVLILLLGA | 751 | Q92729 | |
| GFLGLLVSGFGLDCL | 91 | Q8N7P3 | |
| LLSSVFAVCGLGLLG | 11 | Q9UF02 | |
| CALGLAIGLVGFLVG | 221 | P06340 | |
| ILLLLGGLCIGAGRI | 116 | Q9UBN1 | |
| FLLGFLGPLAIIGTC | 221 | Q8NGA4 | |
| VFGVILGAVCGGLLR | 51 | P43004 | |
| VLCGVAFGLGVLGII | 231 | P28067 | |
| GGQLGLFCGASLITI | 446 | Q9NY37 | |
| LLSSVFGACGLLLVG | 11 | P62955 | |
| ILLGFLGLLLGIAGL | 86 | P56746 | |
| LLLLVLGGCLGVFGV | 26 | P15586 | |
| SGIVGFILSLLCGAL | 191 | Q96IW7 | |
| SRLGFLGLGGCGLIV | 136 | P0C7U9 | |
| LSFIGCLGGELLLQG | 11 | Q9P232 | |
| LIVGTLVCGIVLGFL | 331 | P15509 | |
| YGGLGLGGLLLLAVV | 11 | O00453 | |
| CFGGIIFNILVGVGL | 491 | Q6J4K2 | |
| GLIVALLIGGFDILC | 201 | Q8NH53 | |
| GLICGGLLAIAGIAA | 41 | P59646 | |
| GGLIGLAACSIALGK | 71 | Q08AM6 | |
| LLLGTAAGLGFLCLL | 16 | Q96TC7 | |
| GLLGCILGLIIIVGP | 161 | Q8N808 | |
| LVLLFLGALGLCLAG | 6 | P02788 | |
| FLFCRLISGIGIGGA | 201 | Q7L1I2 | |
| QLGKLIVLGHVFGCL | 606 | Q8NDG6 | |
| GGCGALGLLLLLLGA | 6 | Q8N0V4 | |
| LRGGIFGLLGCLQAI | 986 | O95255 | |
| GFLRKLSLRGCLGVG | 91 | Q96IG2 | |
| GAGICAGLALALIFG | 206 | Q8TDQ0 | |
| LAGLGGLSLLGVFCG | 336 | Q9HAB3 | |
| CLLILVGALVGGIIF | 101 | Q6AI14 | |
| GVLSLLVLCGVLFLG | 41 | A0A2R8YCJ5 | |
| LVLCGVLFLGGGLLL | 46 | A0A2R8YCJ5 | |
| ESCLLILLGLVLGGI | 76 | Q14940 | |
| AGALGVAGLLCAVLG | 11 | Q8WTV0 | |
| GGIGCELLKNLVLTG | 26 | Q9UBT2 | |
| LCLDGGGVKGLIIIQ | 481 | O60733 | |
| AALGRLGLCFGVGVI | 151 | Q96BI1 | |
| LGLCFGVGVILGSLL | 156 | Q96BI1 | |
| LGFLGALAVGTLCGD | 246 | Q6ZMH5 | |
| RLLGCISAGVFLGAG | 46 | Q9NP94 | |
| CFLGILGNGLVIIIA | 51 | Q99788 | |
| GLGLLLLVIICVVGF | 46 | Q8IUN9 | |
| LCGALFITFGILGAL | 286 | Q6UXD7 | |
| FVCCGAGGLLLLIGL | 71 | Q8N0U2 | |
| KVLVIGAGGLGCELL | 71 | Q8TBC4 | |
| LLGCLKGLAGSVRGL | 261 | Q6RFH5 | |
| GCGAIGALVLGAGLL | 101 | A0PJW6 | |
| IGIVLGSLLALGCLA | 266 | P0DPA2 | |
| GALVLLGLGVLLFSG | 201 | Q96AQ6 | |
| ILGLDLGLLAGLIFG | 491 | O43511 | |
| GLVVGILGCLDLGAT | 341 | Q9Y2P5 | |
| CLVLGGALGALGLLR | 136 | Q5BIV9 | |
| GLITCLTGVLGVGLG | 326 | Q9H2V7 | |
| FTCGLIRGGLSNLGI | 121 | Q86SZ2 | |
| GSLLLGLVGGVCTLG | 171 | Q9BXP2 | |
| ILLGVNGGLCLLISL | 231 | Q86VE9 | |
| TGLLLRVLGSLFLGG | 236 | Q9NQQ7 | |
| RIGLHGSGGLCTLVL | 336 | Q4ZJI4 | |
| GCLLLGALGEALLVF | 276 | Q24JQ0 | |
| GIFGLCTALVQILGL | 206 | O14817 | |
| GGVFLILCGLTLIHR | 131 | Q69YG0 | |
| GAFLGIGITALLFLC | 551 | Q96LC7 | |
| LSVRQLCGLLLGGGG | 306 | Q9NQE7 | |
| IRALVGLCKLGSAGG | 496 | Q9H3U1 | |
| AGIALGIGLLCGLVA | 96 | Q66K66 | |
| GLLLGGGLLCALLTL | 151 | Q66K66 | |
| LLGLGISSFVLITGC | 131 | Q96S06 |